NEW YORK STATE COMMON RETIREMENT FUND - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 84 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,000
-98.8%
445
-98.5%
0.00%
Q1 2022$82,000
-37.9%
30,603
+0.3%
0.00%
Q4 2021$132,000
-15.4%
30,512
-0.5%
0.00%
Q3 2021$156,000
-50.2%
30,655
-38.0%
0.00%
Q2 2021$313,000
-5.7%
49,483
+15.1%
0.00%
Q1 2021$332,000
-2.6%
43,000
-17.5%
0.00%
Q4 2020$341,000
-22.3%
52,127
-21.1%
0.00%
-100.0%
Q3 2020$439,000
-20.2%
66,0270.0%0.00%0.0%
Q2 2020$550,000
+50.7%
66,027
+38.9%
0.00%0.0%
Q1 2020$365,000
-11.2%
47,544
-3.8%
0.00%
Q4 2019$411,000
+9.6%
49,427
-2.8%
0.00%
Q3 2019$375,000
-32.7%
50,827
+2.4%
0.00%
-100.0%
Q2 2019$557,000
+3.7%
49,627
-0.7%
0.00%0.0%
Q1 2019$537,000
-29.6%
49,977
-1.1%
0.00%0.0%
Q4 2018$763,000
-20.4%
50,527
-2.4%
0.00%0.0%
Q3 2018$958,000
-27.2%
51,777
-10.1%
0.00%
-50.0%
Q2 2018$1,316,000
-1.3%
57,577
+22.8%
0.00%0.0%
Q1 2018$1,334,000
+48.7%
46,897
+10.4%
0.00%
+100.0%
Q4 2017$897,000
+33.9%
42,477
+15.1%
0.00%0.0%
Q3 2017$670,000
+39.0%
36,900
+18.6%
0.00%0.0%
Q2 2017$482,000
+33.5%
31,100
+48.8%
0.00%
Q1 2017$361,000
+57.0%
20,901
+0.0%
0.00%
Q4 2016$230,000
-29.9%
20,9000.0%0.00%
Q3 2016$328,000
+54.0%
20,9000.0%0.00%
Q2 2016$213,000
+126.6%
20,900
+186.3%
0.00%
Q1 2016$94,0007,3000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders